← Eichor
Condition: Tumor Immunity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Immunity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER
NA · 1 location(s) · Medical University of Graz · NCT07267000Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer
Phase N/A · 1 location(s) · Lars Olaf Cardell · NCT07131566A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06246968A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04683679Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors
EARLY_Phase 1 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06454955Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Neo-adjuvant Immunotherapy Master Trial for Localized Cancers
Phase 2 · 1 location(s) · UNICANCER · NCT07262489OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NA · 1 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT06611072InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction i
Phase N/A · 5 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT04842916A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06863233Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
Phase N/A · 22 location(s) · Fundación GECP · NCT06634199Investigating the Tumour Immune Response of Radiotherapy
Phase N/A · 1 location(s) · University of Manchester · NCT05076500Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06605664Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · 31 location(s) · Dendreon · NCT06134232Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NA · 2 location(s) · Centre Georges Francois Leclerc · NCT04925856Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT06339424Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient
Phase 2 · 2 location(s) · Institute of Oncology Ljubljana · NCT06923787Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06539832A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants
Phase N/A · 2 location(s) · Arkansas Children's Hospital Research Institute · NCT07422337Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
NA · 3 location(s) · Institut Claudius Regaud · NCT03514368BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07564219Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT04517838An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 In
EARLY_Phase 1 · 1 location(s) · Suzhou BlueHorse Therapeutics Co., Ltd. · NCT06697665RFA Plus Carrizumab vs Carrizumab Alone for HCC
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04150744Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
Phase 1 · 1 location(s) · Northwell Health · NCT07361107Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment
NA · 2 location(s) · Université de Sherbrooke · NCT06911970Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04363983Early Detection of Complications During Immunotherapy for Haematological Malignancy
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06377059Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Phase N/A · 2 location(s) · University of Regensburg · NCT04108936
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.